Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
P.J.M. Bouvet, P.A.D. Grimont.
Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov,. Acinetobacter junii sp. nov., and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii.
Int J Syst Bacteriol, 36 (1986), pp. 228-240
[2.]
E. Bergogne-Berezin, K.J. Towner.
Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical, and epidemiological features.
Clin Microbiol Rev, 9 (1996), pp. 148-165
[3.]
J. Rodríguez-Baño, J.M. Cisneros, J. Vila, A. Pascual, L. Martínez-Martínez, G. Bou, et al.
Proyecto GEIH-Ab 2001: estudio multicéntrico de la epidemiología de Acinetobacter baumannii. × Congreso de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC), Sevilla 17-20 de Marzo 2002.
Enferm Infecc Microbiol Clin, 20 (2002), pp. 119
[4.]
J. Rodríguez-Baño, A. Pascual, J. Gálvez, M.A. Muniain, M.J. Ríos, L. Martínez-Martínez, et al.
Bacteriemias por Acinetobacter baumannii: características clínicas y pronósticas.
Enf Infecc Microbiol Clin, 23 (2003), pp. 242-247
[5.]
D. Villers, E. Espaze, M. Coste-Burel, F. Giauffret, E. Ninin, F. Nicolas, et al.
Nosocomial Acinetobacter baumannii infections: Microbiological and clinical epidemiology.
Ann Intern Med, 129 (1998), pp. 182-189
[6.]
D. Martín-Lozano, J.M. Cisneros, B. Becerril, L. Cuberos, M.T. Prados, C. Ortíz-Leyba, et al.
Comparison of a repetitive extragenic palindromic sequence-based PCR method and clinical and microbiological methods for determining strain sources in cases of nosocomial Acinetobacter baumannii bacteremia.
J Clin Microbiol, 40 (2002), pp. 4571-4575
[7.]
I. Das, P. Lambert, M. Noy, J. Bion, T. Elliot.
Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units.
J Hosp Infect, 50 (2002), pp. 110-114
[8.]
L. Fierobe, J.C. Lucet, D. Decré, C. Muller-Serieys, A. Deleuze, M.L. Joly-Guillou, et al.
An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients.
Infect Control Hosp Epidemiol, 22 (2001), pp. 35-40
[9.]
D. Pittet, S. Hugonnet, S. Harbarth, P. Mourouga, V. Sauvan, S. Touveneau, et al.
Effectiveness of a hospital-wide programme to improve compliance with hand hygiene.
Lancet, 356 (2000), pp. 1307-1312
[10.]
J.M. Cisneros, M.J. Reyes, J. Pachón, B. Becerril, F.J. Caballero, J.L. García-Garmendía, et al.
Bacteremia due to Acinetobacter baumannii: epidemiology, clinical and prognostic features.
Clin Infect Dis, 22 (1996), pp. 1026-1032
[11.]
V.M. Manikal, D. Landman, G. Saurina, E. Oydna, H. Lal, J. Quale.
Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage.
Clin Infect Dis, 31 (2000), pp. 101-106
[12.]
J.M. Cisneros, J. Rodríguez-Baño, A. Pascual, L. Martínez-Martínez, J. Vila, G. Bou, et al.
Proyecto GEIH-Ab 2001: características clinicas de la colonización/infección por A. baumannii en hospitales españoles. × Congreso de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC), Sevilla 17-20 de Marzo 2002.
Enferm Infecc Microbiol Clin, 20 (2002), pp. 120
[13.]
H. Wisplinghoff, W. Perbix, H. Seifert.
Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: a case-control study of adult burn patients.
Clin Infect Dis, 28 (1999), pp. 59-66
[14.]
J.L. García-Garmendia, C. Ortiz-Leyba, J. Garnacho-Montero, F.J. Jiménez-Jiménez, C. Pérez-Paredes, A.E. Barrero-Almodovar, et al.
Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: A cohort study.
Clin Infect Dis, 33 (2001), pp. 939-946
[15.]
J. Vila, M.M. Navia, J. Ruiz, C. Casals.
Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived β-lactamase in Acinetobacter baumannii.
Antimicrob Agents Chemother, 41 (1997), pp. 2757-2759
[16.]
M.M. Navia, J. Ruiz, J. Vila.
Characterization of an integron carrying a new class D β-lactamase (OXA-37) in Acinetobacter baumannii.
Microb Drug Resist, 8 (2002), pp. 261-265
[17.]
X. Corbella, A. Montero, M. Pujol, M.A. Domínguez, J. Ayats, M.J. Argerich, et al.
Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii.
J Clin Microbiol, 38 (2000), pp. 4086-4095
[18.]
Cisneros JM, Rodríguez-Baño J, Vila J, Pascual A, Martínez-Martínez L, Bou G, et al. Risk Factors for Nosocomial Acquisition of Imipenem-Resistant Acinetobacter baumannii. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, USA, September 27-30, 2002. Abstract K-1945
[19.]
P.R. Hsueh, L.J. Teng, A.Y. Chen, W.H. Chen, C.J. Yu, S.W. Ho, et al.
Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan.
Emerg Infect Dis, 8 (2002), pp. 827-832
[20.]
H. Wisplinghoff, M.B. Edmond, M.A. Pfaller, R.N. Jones, R. Wenzel, H. Seifert.
Nosocomial bloodstream infections caused by Acinetobacter species in United States Hospitals: Clinical features, molecular epidemiology, and antimicrobial susceptibility.
Clin Infect Dis, 31 (2000), pp. 690-697
[21.]
J.L. García-Garmendia, C. Ortiz-Leyba, J. Garnacho-Montero, J. Jiménez-Jiménez, J. Monterrubio Villar, M. Gili-Miner.
Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients.
Crit Care Med, 27 (1999), pp. 1794-1799
[22.]
J.M. Cisneros, J. Rodríguez-Baño.
Nosocomial bacteremia due to Acinetobacter baumannii: Epidemiology, clinical features and treatment.
Clin Microbiol Infect, 8 (2002), pp. 687-693
[23.]
M.J. Rodríguez-Hernández, J. Pachón, C. Pichardo, L. Cuberos, J. Ibáñez-Martínez, A. García-Curiel, et al.
Imipenem, doxycicline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia.
J Antimicrob Chemother, 45 (2000), pp. 493-501
[24.]
M.E. Jiménez-Mejías, J. Pachón, B. Becerril, J. Palomino-Nicás, A. Rodríguez-Cobacho, M. Revuelta.
Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin-sulbactam.
Clin Infect Dis, 24 (1997), pp. 932-935
[25.]
X. Corbella, J. Ariza, C. Ardanuy, M. Vuelta, F. Tubau, M. Sora, et al.
Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii.
J Antimicrob Chemother, 42 (1998), pp. 793-802
[26.]
G.C. Wood, S.D. Hanes, M.A. Croce, T.C. Fabian, B. Boucher.
Comparison of ampicillin-sulbactam and imipenem-cilastin for the treatment of Acinetobacter ventilator-associated pneumonia.
Clin Infect Dis, 34 (2002), pp. 1425-1430
[27.]
A.S. Levin, A.A. Barone, J. Penco, M.V. Santos, I.S. Mariho, E.A. Arruda, et al.
Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
Clin Infect Dis, 28 (1999), pp. 1008-1011
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
